Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.24.2
CONSOLIDATED BALANCE SHEETS - USD ($)
May 31, 2024
Aug. 31, 2023
Current    
Cash $ 8,459,081 $ 1,352,102
Marketable securities 46,307 125,642
Accounts receivable 208,445 126,686
Prepaid expenses and other current assets 379,546 546,783
Total Current Assets 9,093,379 2,151,213
Non-current assets, net    
Long-term receivables 63,575 48,559
Right of use assets 143,316 167,446
Intellectual property, net 498,878 462,625
Property & equipment, net 219,289 254,143
Total Non-current Assets 925,058 932,773
TOTAL ASSETS 10,018,437 3,083,986
Current Liabilities    
Accounts payable and accrued liabilities 128,788 239,941
Lease liability, current 27,260 27,794
Total Current Liabilities 156,048 267,735
Lease liabilities - non-current 115,327 136,173
TOTAL LIABILITIES 271,375 403,908
Stockholders' Equity    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding: 15,810,205 and 8,091,650 at May 31, 2024, and August 31, 2023, respectively. 15,810 8,091
Additional paid-in capital 59,502,668 48,799,454
Accumulated deficit (49,373,982) (45,763,427)
Accumulated other comprehensive loss (21,866) 0
Equity attributable to shareholders of Lexaria 10,122,630 3,044,118
Non-controlling interest (375,568) (364,040)
Total Stockholders' Equity 9,747,062 2,680,078
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 10,018,437 $ 3,083,986